M4MM
atai Life Sciences Initiates Phase 2 Trial of EMP-01 for Social Anxiety Disorder
LOS ANGELES- atai Life Sciences has commenced a Phase 2 clinical trial evaluating EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine (R-MDMA), for the treatment of social anxiety disorder (SAD). The first patient has been dosed in ...
Village Farms International Reports Q1 2025
LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...
Legalization Significantly Reduces Canada’s Illicit Cannabis Market
LOS ANGELES- Recent analyses indicate that Canada's legalization of non-medical cannabis in 2018 has substantially shifted consumer spending from illicit to legal markets. Studies report that within five years of legalization, approximately 75% of cannabis ...
Worried About IRS Audits? What You Need to Know
LOS ANGELES– The cannabis and psychedelics industry is undergoing a remarkable transformation, and as we one step into 2025, the outlook is brighter than ever. With increasing legalization, growing consumer acceptance, and a burgeoning market ...
Psilocybin Therapy Shows Promise for Pandemic-Induced Depression in Healthcare Workers
LOS ANGELES- Recent studies indicate that psilocybin-assisted psychotherapy may alleviate depression among healthcare professionals affected by the COVID-19 pandemic. A randomized clinical trial conducted by the University of Washington involved 30 frontline clinicians experiencing moderate to ...
Efficacy of Medical Cannabis in Treating PTSD Remains Uncertain
LOS ANGELES- The use of medical cannabis as a treatment for post-traumatic stress disorder (PTSD) has garnered significant attention. However, current research provides limited and inconclusive evidence regarding its effectiveness. A 2021 systematic review found ...
Compass Pathways Advances Psilocybin Research in the UK
LOS ANGELES- Compass Pathways, a biotechnology company specializing in mental health innovations, has commenced the UK segment of its global Phase 3 clinical trial evaluating COMP360 psilocybin therapy for treatment-resistant depression (TRD). This initiative follows ...
atai Life Sciences Initiates Phase 2 Trial of EMP-01 for Social Anxiety Disorder
LOS ANGELES- atai Life Sciences has commenced a Phase 2 clinical trial evaluating EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine (R-MDMA), for the treatment of social anxiety disorder (SAD). The first patient has been dosed in ...
Village Farms International Reports Q1 2025
LOS ANGELES- Village Farms International Inc. has announced its financial results for the first quarter of 2025, highlighting a strategic pivot towards its cannabis operations and the privatization of certain fresh produce assets. For the ...
Legalization Significantly Reduces Canada’s Illicit Cannabis Market
LOS ANGELES- Recent analyses indicate that Canada's legalization of non-medical cannabis in 2018 has substantially shifted consumer spending from illicit to legal markets. Studies report that within five years of legalization, approximately 75% of cannabis ...
Unity Rd. U.S. Cannabis Franchise Fuels 2022 Growth With New Market Expansion and Pending Transformative Acquisition
PHOENIX, Sept. 7, 2022 - Unity Rd National cannabis dispensary franchise in the U.S., has hit record-breaking milestones in 2022. From a pending acquisition that will expand the brand into the world's second largest cannabis market to ...
SEC, OCS and DOJ Investigate Dan Bilzerian’s Ignite Cannabis Company
TORONTO-Dan Bilzerian is under investigation by investigators from the US and Canadian governments. With more than 30 million followers on Instagram alone, Dan is regarded as the ''King of Instagram,'' but with the latest news, ...
Sproutly Announces Cease Trade Order
VANCOUVER, BC, Sept. 6, 2022 Sproutly Canada, Inc. Sproutly announced today that, the British Columbia Securities Commission has issued a general "failure to file" cease trade order pursuant to National Policy 11-207 – Failure to File ...
The Green Organic Dutchman Closes Sale Of HemPoland Subsidiary
TORONTO, Sept. 6, 2022 The Green Organic Dutchman Holdings Ltd. is pleased to announce that it has closed the sale of its Polish subsidiary, HemPoland sp. Under the terms of a share purchase agreement, TGOD ...
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
BERLIN - Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), global cannabis and consumer packaged goods company, today announced that the Company has initiated a policy roundtable with German regulators on adult-use cannabis legalization in Germany. ...
Global Cannabis Concentrate Market Size Worth $18.5 Billion by 2030 at a 25.04% CAGR
Sandy, United States - Custom Market Insights has published a new research report titled “Cannabis Concentrate Market Size, Trends and Insights By Type (Live Resins, Wax, Oil, Chatter, Vape), By End User (Medical, Recreational Next, ...
Generation Hemp Officially Launches Gas Monkey Spill-Jack Hemp Product Line
DALLAS, Sept. 6, 2022 Generation Hemp, Inc., in collaboration with Richard Rawlings' Gas Monkey Garage, today announced the official launch of its Gas Monkey Spill-Jack consumer goods hemp product line. Gas Monkey Spill-Jack is an ...
Wild Theory Announces Strata Full Spectrum CBD + THC Gummies with 0.3% THC
MADISON, Wisc., Sept. 2, 2022 Wild Theory CBD Co., a family-owned CBD company in Madison, Wisconsin, is thrilled to announce its latest and most potent CBD product: Strata Full Spectrum CBD + THC Gummies. The ...
United States Cannabinoids Market Analysis Report 2022-2030
The U.S. cannabinoids market size is expected to reach USD 60.4 billion by 2030 and is expected to expand at a CAGR of 16.2% Growing awareness regarding the health benefits provided by cannabinoids and the ...
Good Supply Launches New High-Potency Product Drop and Unveils Exclusive Orange Frost Live Resin
TORONTO - Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life today announced the expansion of ...
TREES RECEIVES LICENSE TO OPERATE IN BRITISH COLUMBIA, AND COMMENCES WITH CLOSING OF 5-STORE B.C. ASSET ACQUISITION
TORONTO, Sept. 2, 2022 Trees Corporation is pleased to announce that it is now provincially licensed to operate in British Columbia, having received due diligence approval from the British Columbia Liquor and Cannabis Regulation Branch. ...
Curaleaf Annual Meeting of Shareholders Reminder
WAKEFIELD, Mass., Sept. 2, 2022 Curaleaf Holdings, Inc. a provider of consumer products in cannabis, reminds its shareholders that its annual meeting (the "Meeting") will be held on September 8, 2022 at 2:00 p.m. (Eastern ...
Khiron, Launches New Cannabis Products in Europe including Stellar Genetics from California
TORONTO, Sept. 1, 2022 Khiron Life Sciences Corp. Announces its new medical product portfolio in Europe. The new products, which are already being promoted to prescribers, pharmacies, and patients, will be exclusively distributed through Khiron's wholly-owned Pharmadrug Production ...
Glass House Brands Closes Initial Tranche of Non-Brokered Private Placement of Equity Securities
LONG BEACH, Calif. and TORONTO, Sept. 1, 2022 /CNW/ - Glass House Brands Inc. Today announced the closing of the first tranche of the previously announced non-brokered private placement (the "Offering") of Series B Preferred ...
National Cannabis Risk Prevention Services Names Andrew Hatch As Director of Product Safety; Launches Its Product Safety Risk Program
DURANGO, Colo., Aug. 31, 2022 A cannabis botanist has been named director of product safety for National Cannabis Risk Prevention Services, preparing the organization to launch and build a product safety program to serve the ...
